NEWARK, Calif.--(BUSINESS WIRE)--Vector Laboratories, the pioneer of innovative proteomic and glycomic research solutions, and Navinci Diagnostics, leader of innovative in situ proximity ligation ...

The new kit combines Vector’s validated lectins with Navinci’s in situ PLA technology to gain insights beyond protein expression The Glysite™ Explorer in situ PLA Glycan Detection Kit is a fully ...

GTCR, a leading private equity firm, today announced that it has completed a strategic equity investment in Vector Laboratories, Inc. (“Vector” or the “Company”), through GTCR’s previously established ...

Vector Laboratories, a manufacturing partner of reagents and critical components for the development and production of life sciences tools, diagnostics, and clinical-stage biotherapeutics, announced ...

LONG BEACH, Calif.--(BUSINESS WIRE)--Rocket Lab USA, Inc. (“Rocket Lab” or “the Company”), a global leader in launch and space systems, and Vector Acquisition Corporation (Nasdaq: VACQ) (“Vector”), a ...

Gross proceeds to Rocket Lab totaled $777 million, combining funds held in Vector Acquisition Corporation's trust account and concurrent PIPE financing Transaction proceeds expected to accelerate ...

The collaboration between Vector Laboratories and Navinci Diagnostics will empower researchers’ ability to understand the glycosylation state of specific protein targets in the spatial context of ...

The new kit combines Vector's validated lectins with Navinci's in situ PLA technology to gain insights beyond protein expression Vector Laboratories, a leader in innovative proteomic and glycomic ...

Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or the “Company”), a global leader in launch services and space systems, today announced that it completed its previously announced merger with Vector ...